10 Results for "

Uric acid (Standard)

" in MedChemExpress (MCE) Product Catalog:
Products (10)

10 Results for "Uric acid (Standard)" in MCE Product Catalog:

Cat. No.: HY-B2130R
CAS No.: 69-93-2
Uric acid (Standard) is the analytical standard of Uric acid (HY-B2130). This product is intended for research and analytical applications. Uric acid is an orally active oxygen free radical scavenger that helps maintain stable blood pressure and combat oxidative stress. Uric acid can scavenge ROS, such as singlet oxygen and peroxynitrite, and inhibit lipid peroxidation. Uric acid can be used as a modeling agent in research on hyperuricemia-induced hypertension models .
loading...
    loading...
Cat. No.: HY-113063R
CAS No.: 1460-34-0
3-Methyl-2-oxovaleric acid (Standard) is the analytical standard of 3-Methyl-2-oxovaleric acid (HY-113063). This product is intended for research and analytical applications. 3-Methyl-2-oxovaleric acid is a degradation product from Isoleucine. 3-Methyl-2-oxovaleric acid is a biomarker of mustard airway diseases (MADs) and uric acid stone.
loading...
    loading...
Cat. No.: HY-W017389R
CAS No.: 69-89-6
Xanthine (Standard) is the analytical standard of Xanthine. This product is intended for research and analytical applications. Xanthine, a plant alkaloid found in tea, coffee, and cocoa, is a mild stimulant of the central nervous system. Xanthine also acts as an intermediate product on the pathway of purine degradation . In Vitro: A number of stimulants are derived from Xanthine including caffeine and theobromine. Xanthine is a product on the pathway of purine degradation. Xanthine is subsequently converted to uric acid by the action of the Xanthine oxidase enzyme.
loading...
    loading...
Cat. No.: HY-B2130AR
CAS No.: 1198-77-2
Synonyms: Monosodium urate (Standard)
Uric acid sodium (Standard) (Monosodium urate (Standard)) is the analytical standard of Uric acid sodium (HY-B2130A). This product is intended for research and analytical applications. Uric acid sodium is an orally active oxygen free radical scavenger that helps maintain stable blood pressure and combat oxidative stress. Uric acid sodium can scavenge ROS, such as singlet oxygen and peroxynitrite, and inhibit lipid peroxidation. Uric acid sodium can be used as a modeling agent in research on hyperuricemia-induced hypertension models .
loading...
    loading...
Cat. No.: HY-W011711R
CAS No.: 1477-19-6
Research Areas:  

Metabolic Disease

Benzarone (Standard) is the analytical standard of Benzarone. This product is intended for research and analytical applications. Benzarone is a potent human uric acid transporter 1 (hURAT1) inhibitor, with an IC50 of 2.8 μM in oocyte. Benzarone could lower uric acid serum levels .
loading...
    loading...
Cat. No.: HY-W007346R
CAS No.: 591-31-1
Synonyms: 3-Methoxybenzaldehyde (Standard)
m-Anisaldehyde (Standard) (3-Methoxybenzaldehyde (Standard)) is the analytical standard of m-Anisaldehyde (HY-W007346). This product is intended for research and analytical applications. m-Anisaldehyde (3-Methoxybenzaldehyde) is an aromatic aldehyde that exhibits low fumigant insecticidal activity against Lycoriella ingenua larvae. m-Anisaldehyde is a characteristic serum metabolite that is negatively correlated with uric acid in late pregnancy and negatively correlated with thyroid autoantibodies TPOAb and TgAb. m-Anisaldehyde can be used in studies of thyroid autoimmunity .
loading...
    loading...
Cat. No.: HY-W012658R
CAS No.: 577-16-2
Synonyms: O-Methylacetophenone (Standard)
2-Methylacetophenone (O-Methylacetophenone) (Standard) is the analytical standard of 2-Methylacetophenone (HY-W012658). This product is intended for research and analytical applications. 2-Methylacetophenone (O-Methylacetophenone), acetophenone derivative and acaricide, is a xanthine dehydrogenase (XDH) inhibitor. 2-Methylacetophenone competitively binds to the XDH active site, blocking the pathway for xanthine to be converted to uric acid. 2-Methylacetophenone can be used for the study of hyperuricemia and house dust .
loading...
    loading...
Cat. No.: HY-145453R
CAS No.: 66532-85-2
Propacetamol (Standard) is the analytical standard of Propacetamol (HY-145453). This product is intended for research and analytical applications. Propacetamol is an orally active prodrug of Acetaminophen (HY-66005), which exerts antipyretic and analgesic effects after metabolism. Propacetamol reduces Aspirin (ASA) (HY-14654)-induced elevation of malondialdehyde (MDA) in gastric mucosa and plasma, regulates the levels of gastric mucosal glutathione (GSH and GSSG) to maintain cellular antioxidant defense, and increases gastric mucosal uric acid (UA) levels. Propacetamol exerts a dose-dependent protective effect against ASA-induced gastric mucosal damage in rats. Propacetamol can be used for the study of gastric mucosal injury by interfering with oxidative stress .
loading...
    loading...
Cat. No.: HY-Y0106R
CAS No.: 699-83-2
2,6-Dihydroxyacetophenone (Standard) is the analytical standard of 2,6-Dihydroxyacetophenone (HY-Y0106). This product is intended for research and analytical applications. 2,6-Dihydroxyacetophenone, a polyphenolic derivative of Acetophenone (HY-Y0989), is an orally active mTOR inhibitor. 2,6-Dihydroxyacetophenone shows antioxidant activity. 2,6-Dihydroxyacetophenone inhibits cell growth and proliferation in CRC cells. 2,6-Dihydroxyacetophenone arrests at G0/G1 phase of cell cycle, induces apoptosis and suppresses cell migration in CRC cells. 2,6-Dihydroxyacetophenone inhibits xanthine oxidase (XOD) with an IC50 of 1.24 mM. 2,6-dihydroxyacetophenone improves uric acid metabolism in hyperuricemia mice, reduces plasma cholesterol in hypercholesterolemic rats, and inhibits lipid accumulation in HFD-induced obese mice. 2,6-Dihydroxyacetophenone can be used for the study of colorectal cancer (CRC), hyperuricemia and hypercholesterolemia .
loading...
    loading...
Cat. No.: HY-100712R
CAS No.: 43077-30-1
DPO-1 (Standard) is the analytical standard of DPO-1 (HY-100712). This product is intended for research and analytical applications. DPO-1 is a potent Kv1.5 and Kv1.3 (EC50 = 3.1 μM) channels inhibitor with potential immunomodulatory and anti-inflammatory effects. DPO-1 reduces Kv1.3 current density, blunts Ca2+ influx in Ca2+-depleted Jurkat cells, and inhibits IL-2 secretion in activated Jurkat cells. DPO-1 inhibits Uric acid sodium (HY-B2130A) (MSU)-induced NLRP3 inflammasome activation by blocking Kv1.5-mediated K+ efflux. DPO-1 can be used for the study of immunologic disorders and atrial fibrillation .
loading...
    loading...